Microparticles in Severe Aortic Stenosis
NCT02193035 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2016-04-13
Summary
Microparticles are small cell fragments that can induce fat plaques, calcification and formation of thrombus. They can be released through multiple stimulations, but also the high flow of blood through partially obstructed aortic valves.
In patients with severely obstructed aortic valves the investigators hypothesize that microparticles levels will be elevated and that they will go down after percutaneous treatment of the valves.
Conditions
- Aortic Valve Stenosis
Interventions
- OTHER
-
Microparticle levels
Microparticle levels will be evaluated with flow cytometry and nanoparticle tracking analysis
Sponsors & Collaborators
-
InCor Heart Institute
lead OTHER
Principal Investigators
-
Pedro Lemos, MD PhD · Heart Institute - InCor. University of Sao Paulo Medical School
-
Julio F Marchini, MD PhD · Heart Institute - InCor. University of Sao Paulo Medical School
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- Brazil
Study Locations
More Related Trials
-
STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT
NCT05785897 ·Status: RECRUITING ·Phase: NA
-
Wall Shear Stress and Neointimal Healing Following PCI in Angulated Coronary Vessels
NCT02098876 ·Status: COMPLETED ·Phase: NA
-
Trial for MicroPort's DCB
NCT04386213 ·Status: UNKNOWN ·Phase: NA
-
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)
NCT01120379 ·Status: COMPLETED
-
EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn
NCT06675617 ·Status: RECRUITING ·Phase: NA
-
Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy
NCT05952206 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Trial Evaluating New Strategy in the Functional Assessment of 3-vessel Disease Using SYNTAXII Score in Patients With PCI
NCT02015832 ·Status: COMPLETED
-
Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent
NCT00793221 ·Status: COMPLETED ·Phase: PHASE3
-
Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction
NCT00433966 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety Study of ABI-007 for In-Stent Restenosis
NCT00093223 ·Status: COMPLETED ·Phase: PHASE2
-
Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)
NCT01078051 ·Status: TERMINATED ·Phase: PHASE4
-
Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques
NCT00916695 ·Status: UNKNOWN ·Phase: PHASE4
-
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease
NCT02831205 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary Artery Stenosis (PRE-COMBAT 2)
NCT01348022 ·Status: COMPLETED
-
Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
NCT06863155 ·Status: RECRUITING
-
Comparison of the Biolimus A9-eluting Stent With the Zotarolimus -Eluting Stent in Multi-vessel PCI
NCT01947439 ·Status: COMPLETED ·Phase: NA
-
Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerosis
NCT02845804 ·Status: UNKNOWN
-
IVUS Controlled Stenting
NCT02128412 ·Status: UNKNOWN ·Phase: NA
-
A Study to Examine the Implantation Characteristics of Two Drug-Eluting Stents
NCT01201369 ·Status: COMPLETED ·Phase: NA
-
Stenting With or Without Coating Compared With Angioplasty in Non-benestent Disease
NCT00192881 ·Status: UNKNOWN ·Phase: NA
-
Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES
NCT04135989 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
NCT01498692 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Vasomotor Function and Myocardial Flow in Patients Treated With Bioresorbable and Metallic Stents at 1 Year
NCT02738658 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period
NCT00882219 ·Status: COMPLETED ·Phase: PHASE3
-
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen
NCT01267734 ·Status: UNKNOWN ·Phase: PHASE4